How many studies have been conducted on Chemokine Ccl22?

BiohacksAI has indexed 135 PubMed studies on Chemokine Ccl22, including 3 randomized controlled trials (RCTs). 38% of studies involve human subjects.

What are the main research areas for Chemokine Ccl22?

The primary research domains for Chemokine Ccl22 are 🛡️ Immunity, 🔬 Inflammation, 🔬 Oncology. This is based on analysis of 135 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Chemokine Ccl22

A CC-type chemokine with specificity for CCR4 RECEPTORS. It has activity towards TH2 CELLS and TC2 CELLS.

135+ PubMed studies analyzed · 3 RCTs · Evidence Score: 48.3

Research Domains

Chemokine Ccl22 has been studied across 15 research domains including 🛡️ Immunity, 🔬 Inflammation, 🔬 Oncology, 🫁 Respiratory, ✨ Skin & Hair. The primary research focus is 🛡️ Immunity with 33% of studies addressing this area.

Loading evidence profile...

This evidence profile for Chemokine Ccl22 is generated deterministically from 135 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.